CLEVELAND, May 16, 2019 /PRNewswire/ -- ViewRay, Inc.
(NASDAQ: VRAY) today announced that the Company will participate in
the Jefferies 2019 Global Healthcare Conference in New York, New York. Scott Drake, President and CEO, will participate
in a fireside chat at 8:30 a.m. Eastern Time
on Thursday, June 6, 2019.
An audio webcast of the Company's presentation will be available
on the investor relations section of ViewRay's website at
www.viewray.com. A replay of the webcast will be available for
7 days after the date of the presentation.
About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY), designs,
manufactures and markets the MRIdian® radiation therapy system.
MRIdian is built upon a proprietary high-definition MR imaging
system designed from the ground up to address the unique challenges
and clinical workflow for advanced radiation oncology. Unlike MR
systems used in diagnostic radiology, MRIdian's high-definition MR
was purposely built to deliver high-precision radiation without
unnecessary beam distortion, and consequently, help to mitigate
skin toxicity and other safety concerns that may otherwise arise
when high magnetic fields interact with radiation beams. ViewRay
and MRIdian are registered trademarks of ViewRay, Inc.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-jefferies-2019-global-healthcare-conference-300850878.html
SOURCE ViewRay, Inc.